Physician profile
Jeffrey Eifler
NPI 1003178690
$3,694.54
in general payments reported to CMS, 2019-2025
16 companies · $599 in 2025
The $599 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $27.09 · 2021: $112 · 2022: $319 · 2023: $2,013 · 2024: $372 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,498 · Travel and Lodging: $1,486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,498.04 |
| Travel and Lodging | $1,485.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,108.20 | 2019-2025 | Inbone, Prostep, Invision |
| Smith+Nephew, INC. | $169.81 | 2019-2025 | Grafix Pl, Oasis, Stravix Pl |
| Misonix INC | $100.70 | 2019-2021 | |
| Nevro Corp. | $65.50 | 2021-2022 | |
| Orthofix Medical, INC. | $41.34 | 2020-2025 | Physio-Stim |
| Wright Medical Technology, INC. | $25.53 | 2019 | |
| Bioventus LLC | $25.30 | 2022 | |
| Zimmer Biomet Holdings, INC. | $23.86 | 2019 | |
| Integra Lifesciences Corporation | $20.50 | 2022 | |
| Abbvie INC. | $20.21 | 2022 | |
| Dexcom, INC. | $17.22 | 2023 | Dexcom G6 Transmitter |
| Idorsia Pharmaceuticals US INC | $17.09 | 2023 | Quviviq |
| Kerecis Limited | $17.03 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Amniox Medical, INC. | $15.97 | 2019 | |
| Novo Nordisk INC | $14.53 | 2023 | Rybelsus, Ozempic |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Eifler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.